Assignee
CADENT THERAPEUTICS INC
US·15 granted patents·4 pending applications·66 citations·filing 2016–2021
Top patents by PatentIndex Score
19 records- 0196US11236104B2Heteroaromatic NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2020·Granted Feb 1, 2022·4 cites·28 claims
- 0294US10626122B2Heteroaromatic NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2016·Granted Apr 21, 2020·8 cites·16 claims
- 0393US10500205B2Thienopyrimidinone NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2016·Granted Dec 10, 2019·10 cites·22 claims
- 0493US9975886B1Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2018·Granted May 22, 2018·9 cites·2 claims
- 0591US10752633B2Heteroaromatic NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·9 cites·5 claims
- 0691US10584131B2Heteroaromatic NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2019·Granted Mar 10, 2020·9 cites·2 claims
- 0790US10973825B2Thienopyrimidinone NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2016·Granted Apr 13, 2021·6 cites·16 claims
- 0887US11541057B2Thienopyrimidinone NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·1 cites·9 claims
- 0987US11274107B2NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2017·Granted Mar 15, 2022·3 cites·20 claims
- 1086US11542264B2Heteroaromatic NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·1 cites·2 claims
- 1186US10351553B2Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·3 cites·6 claims
- 1281US10781174B2N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2BCADENT THERAPEUTICS INC·Filed 2019·Granted Sep 22, 2020·1 cites·31 claims
- 1380US10717728B2Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2019·Granted Jul 21, 2020·1 cites·7 claims
- 1472US10774064B2Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2017·Granted Sep 15, 2020·1 cites·17 claims
- 1571US11116749B2Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2BCADENT THERAPEUTICS INC·Filed 2018·Granted Sep 14, 2021·0 cites·9 claims
- 1670US2020369610A1N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of nr2bCADENT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1767US2021380571A1Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1840US2018207138A1Methods for the treatment of tremors by positive modulation of sk channelsCADENT THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1939US2017355708A1Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CADENT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →